@TumorBoardTues @hoperugo @laura_huppert @ErikaHamilton9 @MPishvaian @PTarantinoMD @stolaney1 @drteplinsky @JaniceTNBCmets @UCSFCancer 2/3 #TumorBoardTuesday
Thurs Case🎀
Take🏠:
✅HER2 LOW= IHC1+ OR IHC2+ w - ISH (67% HR+!)
✅T-DXd= after 1L chemo in HER2 low
✅Careful monitoring for ILD!
📚We captured @hoperugo & @LauraHuppert’s discussion in below:
twitter.com/i/events/15588…
twitter.com/i/events/15601…
@TumorBoardTues @hoperugo @laura_huppert @ErikaHamilton9 @MPishvaian @PTarantinoMD @stolaney1 @drteplinsky @JaniceTNBCmets @UCSFCancer @LauraHuppert 2.75/3 #TumorBoardTuesday
Check out this graphic outlining the key role for ADCs in the tx of HER2 low #MBC after prior 1L chemo and endocrine therapy.
Hoping for even more changes in the near future w
DB-06!
@TumorBoardTues @hoperugo @laura_huppert @ErikaHamilton9 @MPishvaian @PTarantinoMD @stolaney1 @drteplinsky @JaniceTNBCmets @UCSFCancer @LauraHuppert @esinghimd @HemoncUcsf @UICHemOnc @Hopkins_HemOnc @TheFellowOnCall @jacobadashek 3/3 #TumorBoardTuesday
Special thanks to @hoperugo & @laura_huppert. It is a privilege to hear from experts who are re-defining tx for #breastcancer w next gen ADCs!
Join us on August 30 as @HosseinBorghaei discusses the latest in stage III #NSCLC!
@TumorBoardTues @hoperugo @laura_huppert @ErikaHamilton9 @MPishvaian @PTarantinoMD @stolaney1 @drteplinsky @JaniceTNBCmets @UCSFCancer @LauraHuppert @esinghimd @HemoncUcsf @UICHemOnc @Hopkins_HemOnc @TheFellowOnCall @jacobadashek @HosseinBorghaei @nancyjmac1 @dra_izabela @nwabudike_sm @Nat71553043 @MridulaGeorgeMD @Rick_Villalobos @s_santiesteban @kazuki_nozawa @OlgaMartnezSez1 @BarbaraPistill2 @NagiSaghir @Myshastry @geneman20042000 @drsarahsam @DFCI_BreastOnc @nlinmd @elmayermd @silke4senate
@TumorBoardTues @hoperugo @laura_huppert @ErikaHamilton9 @MPishvaian @PTarantinoMD @stolaney1 @drteplinsky @JaniceTNBCmets @UCSFCancer @LauraHuppert @esinghimd @HemoncUcsf @UICHemOnc @Hopkins_HemOnc @TheFellowOnCall @jacobadashek @HosseinBorghaei @nancyjmac1 @dra_izabela @nwabudike_sm @Nat71553043 @MridulaGeorgeMD @Rick_Villalobos @s_santiesteban @kazuki_nozawa @OlgaMartnezSez1 @BarbaraPistill2 @NagiSaghir @Myshastry @geneman20042000 @drsarahsam @BreastCaupdates @Dr_Ivanoncologo @FilippoMontemu1 @MeiWeiOncology @martha_carlson @BSBreastCancer @ESchattner @DarcyBurbage @sandycassanelli @mabelonc @PTarantinoMD @chrissilveira77 @DrKathThompson @DrGattiMays @AnaMariaUrdan19 @PiotrOkupski @DraDolo @jamienholloway
@TumorBoardTues @hoperugo @laura_huppert @ErikaHamilton9 @MPishvaian @PTarantinoMD @stolaney1 @drteplinsky @JaniceTNBCmets @UCSFCancer @LauraHuppert @esinghimd @HemoncUcsf @UICHemOnc @Hopkins_HemOnc @TheFellowOnCall @jacobadashek @HosseinBorghaei @nancyjmac1 @dra_izabela @nwabudike_sm @Nat71553043 @MridulaGeorgeMD @Rick_Villalobos @s_santiesteban @kazuki_nozawa @OlgaMartnezSez1 @BarbaraPistill2 @NagiSaghir @Myshastry @geneman20042000 @drsarahsam @BreastCaupdates @Dr_Ivanoncologo @FilippoMontemu1 @MeiWeiOncology @martha_carlson @LubnaChaudhary1 @AlisonSvoboda @NagiSaghir @VeroniqueDebien @IBCradiation @Thiago_Apolinar @Timharvey32Lisa @carolinesouthal @maggiedinomemd @katsuki_arima @YukinoriOzaki @Icro_Meattini @DrJamesJakub
@TumorBoardTues @hoperugo @laura_huppert @ErikaHamilton9 @MPishvaian @PTarantinoMD @stolaney1 @drteplinsky @JaniceTNBCmets @UCSFCancer @LauraHuppert @esinghimd @HemoncUcsf @UICHemOnc @Hopkins_HemOnc @TheFellowOnCall @jacobadashek @HosseinBorghaei @nancyjmac1 @dra_izabela @nwabudike_sm @Nat71553043 @MridulaGeorgeMD @Rick_Villalobos @s_santiesteban @kazuki_nozawa @OlgaMartnezSez1 @BarbaraPistill2 @NagiSaghir @Myshastry @geneman20042000 @drsarahsam @BreastCaupdates @Dr_Ivanoncologo @FilippoMontemu1 @MeiWeiOncology @martha_carlson @LubnaChaudhary1 @AlisonSvoboda @VeroniqueDebien @IBCradiation @Thiago_Apolinar @Timharvey32Lisa @carolinesouthal @maggiedinomemd @katsuki_arima @Gobnait @naborala @Dr_RShatsky @AChargy
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.